PanTheryx Stock

PanTheryx.comBioTechFounded: 2007Funding to Date: $137.56MM

PanTheryx is a nutrition and biotechnology company committed to the global commercialization of bovine colostrum-based health and wellness solutions.

Register for Details

For more details on financing and valuation for PanTheryx, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

Already registered? Click here to log in

Team

Management Team

Wes Parris
Chief Executive Officer
James Hau
Chief Financial Officer
Amy Gibbs
Controller
Bimla Starzl
Co-Founder
Mark Grabowsky
Chief Medical Officer

Board Members

Craig Cogut JD
Pegasus Capital Advisors
David Cogut
Pegasus Capital Advisors
Mark Braman
PanTheryx
Peter Vitulli

Other companies like PanTheryx in the BioTech sector

Sector
Last Round Est. Valuation
$143.8MM
Sector
Last Round Est. Valuation
$4.26B
Sector
Last Round Est. Valuation
$50.4MM
Sector
Last Round Est. Valuation
$185MM
Sector
Last Round Est. Valuation
$500MM
Sector
Last Round Est. Valuation
$138.75MM
Sector
Last Round Est. Valuation
$4.89B
Sector
Last Round Est. Valuation
$289.42MM
Sector
Last Round Est. Valuation
$1.08B

News

With two acquisitions, a Boulder company has become the world's largest manufacturer of a rare, nutrient-rich substance: bovine colostrum.
BOULDER — PanTheryx Inc., a Boulder-based life-science company, announced on Tuesday that it has acquired two companies that process colostrum harvested from cows, a key ingredient in the company’s flagship nutritional product, DiaResQ.
SCOTTSDALE, Ariz. & BOULDER, Colo.--(BUSINESS WIRE)--Instead of just waiting for symptoms to go away, global travelers now have a new way to relieve diarrhea, thanks to a partnership announced today by Passport Health and PanTheryx, Inc.